Page 7 of 10 – SEC Filing
The following constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned (“Amendment No. 3”). This Amendment No. 3 amends the Schedule 13D as specifically set forth herein.
| Item 3. | Source and Amount of Funds or Other Consideration. |
| | Item 3 is hereby amended and restated to read as follows: |
The Shares purchased by each of Brosh and Exodus, and held in the Exodus Managed Account were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted in Schedule B, which is incorporated herein by reference. The aggregate purchase price of the 1,296,564 Shares owned directly by Brosh is approximately $1,328,535, excluding brokerage commissions. The aggregate purchase price of the 1,562,397 Shares owned directly by Exodus is approximately $1,511,538, excluding brokerage commissions. The aggregate purchase price of the 144,108 Shares held in the Exodus Managed Account is approximately $154,622, excluding brokerage commissions.
| Item 5. | Interest in Securities of the Issuer. |
Items 5(a)-(c) are hereby amended and restated to read as follows:
(a) The aggregate percentage of Shares reported owned by each person named herein is based upon 27,560,920 Shares outstanding, which is the total number of Shares outstanding as reported in the Issuer’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 4, 2016.
| A. | Brosh |
| | (a) | As of the close of business on March 27, 2017, Brosh beneficially owned 1,296,564 Shares. |
Percentage: Approximately 4.7%
| | (b) | 1. Sole power to vote or direct vote: 0 |
| | 2. Shared power to vote or direct vote: 1,296,564 |
| | 3. Sole power to dispose or direct the disposition: 0 |
| | 4. Shared power to dispose or direct the disposition: 1,296,564 |
| | (c) | The transactions in the Shares by Brosh since the filing of Amendment No. 2 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference. |
| B. | Exodus |
| | (a) | As of the close of business on March 27, 2017, Exodus beneficially owned 1,562,397 Shares. |
Percentage: Approximately 5.7%
| | (b) | 1. Sole power to vote or direct vote: 0 |
| | 2. Shared power to vote or direct vote: 1,562,397 |
| | 3. Sole power to dispose or direct the disposition: 0 |
| | 4. Shared power to dispose or direct the disposition: 1,562,397 |
| | (c) | The transactions in the Shares by Exodus since the filing of Amendment No. 2 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference. |
Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)
Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
